This inventor holds 1 USPTO granted patent. Top assignees: Leiden University Medical Center, Stichting Katholieke Universiteit. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 64 
Years Active: 2009
Title: Christofel Jan Janse: Innovator in Malaria Vaccine Development
Introduction
Christofel Jan Janse is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical research, particularly in the development of vaccines against malaria. His innovative work focuses on creating new mutants that can provide long-lasting protection against malaria infections.
Latest Patents
Christofel Jan Janse holds a patent related to the production of new mutants that are defective in the expression of the protein P36p. These mutants are unable to cause malaria, yet they can be utilized as a vaccine, offering long-lasting protection against infections with wild-type malaria.
Career Highlights
Throughout his career, Janse has worked with esteemed institutions such as Leiden University Medical Center and the Catholic University of Nijmegen. His research has been pivotal in advancing the understanding and prevention of malaria.
Collaborations
Some of his notable coworkers include Andrew Paul Waters and Melissa Ruth Van Dijk. Their collaborative efforts have contributed to the success of Janse's research initiatives.
Conclusion
Christofel Jan Janse's work in malaria vaccine development exemplifies the impact of innovative research in combating infectious diseases. His contributions continue to pave the way for future advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile